SE394434B - Forfarande for framstellning av vissa angivna s-triazinderivat och dess farmaceutiskt godtagbara salter - Google Patents

Forfarande for framstellning av vissa angivna s-triazinderivat och dess farmaceutiskt godtagbara salter

Info

Publication number
SE394434B
SE394434B SE7101718A SE171871A SE394434B SE 394434 B SE394434 B SE 394434B SE 7101718 A SE7101718 A SE 7101718A SE 171871 A SE171871 A SE 171871A SE 394434 B SE394434 B SE 394434B
Authority
SE
Sweden
Prior art keywords
procedure
preparation
pharmaceutical acceptable
triazine derivatives
certain stated
Prior art date
Application number
SE7101718A
Other languages
English (en)
Inventor
S Murai
K Yoshida
C Tomioka
Original Assignee
Kakenyaku Kako Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kakenyaku Kako Kk filed Critical Kakenyaku Kako Kk
Publication of SE394434B publication Critical patent/SE394434B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40Nitrogen atoms
    • C07D251/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7101718A 1970-05-13 1971-02-11 Forfarande for framstellning av vissa angivna s-triazinderivat och dess farmaceutiskt godtagbara salter SE394434B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP45040664A JPS4927592B1 (sv) 1970-05-13 1970-05-13

Publications (1)

Publication Number Publication Date
SE394434B true SE394434B (sv) 1977-06-27

Family

ID=12586784

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7101718A SE394434B (sv) 1970-05-13 1971-02-11 Forfarande for framstellning av vissa angivna s-triazinderivat och dess farmaceutiskt godtagbara salter

Country Status (9)

Country Link
US (1) US3740399A (sv)
JP (1) JPS4927592B1 (sv)
BE (1) BE763425A (sv)
CH (1) CH568304A5 (sv)
DE (1) DE2121694B2 (sv)
FR (1) FR2088532A1 (sv)
GB (1) GB1353545A (sv)
NL (1) NL148797B (sv)
SE (1) SE394434B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9611570A (pt) * 1995-11-27 1999-03-30 Idemitsu Kosan Co Derivados de triazina
NO311614B1 (no) * 1996-10-01 2001-12-17 Janssen Pharmaceutica Nv Substituerte diamino-1,3,5-triazinderivater
US6150362A (en) * 1997-12-12 2000-11-21 Henkin; Jack Triazine angiogenesis inhibitors
SI1129079T1 (sl) 1998-11-10 2006-06-30 Janssen Pharmaceutica Nv 2,4-disubstituirani triazinski derivati z anti-HIV aktivnostjo
CN105555779B (zh) * 2013-07-16 2019-05-10 巴斯夫欧洲公司 除草的嗪类
CN106458937A (zh) 2014-04-11 2017-02-22 巴斯夫欧洲公司 作为除草剂的二氨基三嗪衍生物
EP3134391A1 (en) 2014-04-23 2017-03-01 Basf Se Diaminotriazine compounds and their use as herbicides

Also Published As

Publication number Publication date
DE2121694A1 (de) 1971-11-25
GB1353545A (en) 1974-05-22
US3740399A (en) 1973-06-19
JPS4927592B1 (sv) 1974-07-18
BE763425A (fr) 1971-07-16
DE2121694C3 (sv) 1978-04-27
CH568304A5 (sv) 1975-10-31
NL7102022A (sv) 1971-11-16
FR2088532A1 (sv) 1972-01-07
NL148797B (nl) 1976-03-15
DE2121694B2 (de) 1977-08-18

Similar Documents

Publication Publication Date Title
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
SE394678B (sv) Analogiforfarande for framstellning av pyridokinolinderivat
SE408551B (sv) Forfarande for framstellning av vissa angivna n-substituerade-beta-amino-alfa-bensylakrylnitrilderivat av hog renhet
SE395598B (sv) Av betmassa framstelld rokvara och forfarande for framstellning
IT962341B (it) Procedimento di preparazione di derivati di piperidina spiro idantoina
SE394434B (sv) Forfarande for framstellning av vissa angivna s-triazinderivat och dess farmaceutiskt godtagbara salter
SE7511680L (sv) Forfarande for framstellning av furanderivat
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE392615B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE384685B (sv) Forfarande for framstellning av linkomycinderivat
SE395699B (sv) Forfarande for framstellning av kinuklidin-kinolinderivat
SE401829B (sv) Forfarande for framstellning av 5-fenyl-6,7-bensomorfanderivat och salter derav
SE382970B (sv) Forfarande for framstellning av fosgen med utgaende fran klor och koloxid
SE385471B (sv) Forfarande for framstellning av bensobicykloalkanaminer med analgetisk eller anti-inflammatorisk lekemedelsverkan
SE399557B (sv) Forfarande for framstellning av tiantren-, tioxanten- och fenoxatiinderivat
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE396595B (sv) Forfarande for framstellning av difenylamin och derivat derav
SE415659B (sv) Forfarande for framstellning av basiskt substituerade xanten- och tioxantenderivat
SE398230B (sv) Forfarande for framstellning av 1-amino-3-/(pyrrody-1)-fenoxi/-2-propanol och derivat derav med terapeutisk verkan
SE400086B (sv) Forfarande for framstellning av acylerade n(6)- aralkyl-adenosin-derivat
SE409866B (sv) Forfarande for framstellning av adenosinderivat
SE383738B (sv) Forfarande for framstellning av sulfamoyl-bensensulfonamider med terapeutiska egenskaper
SE398232B (sv) Forfarande for framstellning av bensodiazepinderivat
SE380526B (sv) Forfarande for framstellning av derivat av tienobensopyran och tiopyranobensopyran